Fifth Third Bancorp
- SEC CIK
- 0000035527
- Latest filing
- Aug 5, 2026
AXSM holding history
Axsome Therapeutics, Inc. in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings
- Shares (Q2 2026)
- 24,836
- Value
- $6.08M
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 24,836 | $6.08M | <0.1% | +8,622+53.2% | Added | Holders |
| Q1 2026 | 16,214 | $2.74M | <0.1% | +13,737+554.6% | Added | Holders |
| Q4 2025 | 2,477 | $452.4K | <0.1% | +2,265+1,068.4% | Added | Holders |
| Q3 2025 | 212 | $25.7K | <0.1% | +12+6.0% | Added | Holders |
| Q2 2025 | 200 | $20.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 200 | $23.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 200 | $16.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 200 | $18.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 200 | $16.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 200 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 200 | $15.9K | <0.1% | −200−50.0% | Reduced | Holders |
| Q3 2023 | 400 | $28.0K | <0.1% | +200+100.0% | Added | Holders |
| Q2 2023 | 200 | $14.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 200 | $12.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 200 | $15.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 200 | $9.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 200 | $8.00K | <0.1% | +200 | New | Holders |